As White House Prepares Gift to Big Pharma, Rep. Schakowsky, Lawmakers Press President Trump to Get Behind Real Solutions to Bring Down Prescription Drug Costs
As the
An overwhelming majority of Americans agree that prescription drug prices are too high and that we need action to lower prices. The Improving Access to Affordable Prescription Drugs Act, a comprehensive piece of legislation that the group pressed
"We hear time and time again from our constituents across the country about how high prices for life-saving and life-sustaining treatments force patients to choose between their health and their economic security," the lawmakers wrote to
Today's letter to the president, which you can read here, was led by Reps.
The landmark legislationwas introduced earlier this year by
President
The
Dear President Trump:
We are deeply concerned by news reports suggesting that your administration is failing on one of your principal campaign promises, namely that you would bring down prescription drug prices for American consumers. Instead, under your leadership, your administration is reportedly pursuing an executive order that "appears to give the pharmaceutical industry much of what it has asked for."[1] At a time when profits of prescription drug corporations are at an all-time high and patients are skipping doses because of unaffordable drug prices, pursuing such an executive order is an abdication of your responsibilities to the American people.
We are particularly troubled by reports that your administration's draft executive order includes policies that, perversely, would make prescription drugs more expensive here and abroad. In particular, we are concerned that the draft executive order targets the 340B drug pricing program. The 340B program requires pharmaceutical corporations to provide discounts to hospitals and clinics that serve large numbers of low-income patients. Low-income patients in the
Reports also suggest that your draft executive order would direct the
On the campaign trail, you promised to address high drug prices. You supported measures that would allow consumers to access imported, safe, and dependable drugs from overseas and vowed to allow Medicare to negotiate lower prescription drug prices for seniors. After the election, you again said that you would "bring down drug prices."[3] But since taking office, you have not followed through on these campaign promises. Instead, your administration is pursuing an executive order that does not include the solutions you promised or the relief that Americans need, and could actually result in increased prices for the American people.
Simultaneously, your administration and Congressional Republicans are attempting to rip health coverage, including prescription drug coverage, away from millions of Americans. Taking away Americans' health coverage will make the problem of unaffordable medicines even worse, and ineffective proposals from the drug industry are not a solution.
Rather than pursuing policies that disproportionately benefit the prescription drug industry, you owe it to the American people to make good on your promises by pursuing thoughtful, aggressive, comprehensive policies that will tackle the root causes of high prescription drug prices. Our offices have recently introduced or support legislation to do just that. The Improving Access to Affordable Prescription Drugs Act is a comprehensive solution that will bring transparency to drug pricing, increase the affordability of drugs, spur innovation in new treatments, and promote choice and competition in the drug market. It's time we identify and carry out reforms to ensure the federal government's power as both a purchaser and payer can be leveraged to better serve American families who are making impossible choices just to get the treatment they need to survive.
We hear time and time again from our constituents across the country about how high prices for life-saving and life-sustaining treatments force patients to choose between their health and their economic security. Now is the time to address the American people's concerns in a meaningful way. We urge you to stand up to the pharmaceutical corporations, put the needs of patients first, and support a comprehensive approach that offers real solutions that will make a real difference in peoples' lives.
Sincerely,
[1]
[2] ASPE. Prescription Drugs: Innovation, Spending, & Patient Access.
[3] Scherer, Michael. "2016 Person of the Year
Revised Senate Health Care Bill Will Still Damage Country’s Health
U.S. House Narrowly Passes Bill Stripping Rights of Patients Harmed By Medical Negligence
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News